Defense News 

U.S

The US Army has introduced a new blood testing tool called the i-STAT TBI (Traumatic Brain Injury). This device is designed to swiftly detect traumatic brain injuries within a 15-minute window. Developed in collaboration with Abbott Laboratories, the i-STAT TBI can quickly identify biomarkers indicating brain damage. This capability aids medical professionals in determining whether a patient requires further examination, such as a CT scan.

One of the notable features of the i-STAT TBI is its modular design, allowing it to be easily utilized at the bedside of soldiers suspected of suffering from a concussion. Despite its portability, the device is capable of delivering lab-quality results faster than other blood testing devices currently available.

According to Lt. Col. Bradley Dengler, a neurosurgical consultant for the US Army, the swift identification provided by the i-STAT TBI can expedite the transfer of severely injured service members to neurosurgeons, potentially saving lives.

The development of the i-STAT TBI was a priority within the US Army's health system, aimed at addressing the persistent challenge faced by frontline medical providers in areas where blast exposure is common.

The significance of this device lies in its potential to reduce unnecessary evacuations. With nearly half a million American troops experiencing traumatic brain injuries between 2000 and 2023, the i-STAT TBI can help maintain combat effectiveness by minimizing the need for non-essential medical evacuations.

Having received clearance from the US Food and Drug Administration, the i-STAT TBI stands ready to support military medical personnel in their efforts to provide timely and effective care to injured service members.